Neurogene Inc.NGNENASDAQ

Revenue (LTM)

$925000

Net Income (LTM)

$-75M

-106.9% YoY

Free Cash Flow

$-71M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	1
Gross Profit	-2	-42↓2220.9%	-3↑92.4%	-3↓2.1%	-2↑28.8%
Operating Income	-42	-51↓21.6%	-57↓11.8%	-56↑1.7%	-83↓48.6%
Net Income	-33	-51↓51.8%	-55↓9.2%	-36↑34.2%	-75↓106.9%
EBITDA	-31	-50↓57.6%	-52↓4.8%	-52↓0.6%	-72↓37.5%
EPS Diluted	-0.64	-0.92↓43.8%	-4.30↓367.4%	-2.83↑34.2%	-4.28↓51.2%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	193	71↓63.4%	82↑16.3%	148↑80.7%	137↓7.8%
Total Current Assets	195	74↓62.0%	85↑14.6%	200↑136.5%	316↑57.7%
Total Assets	211	101↓51.8%	109↑7.7%	223↑103.7%	336↑50.8%
Total Current Liabilities	8	11↑37.6%	7↓38.7%	23↑245.4%	15↓34.0%
Total Liabilities	19	193↑901.7%	11↓94.5%	37↑243.6%	25↓30.6%
Total Equity	191	-92↓148.0%	99↑207.3%	186↑88.6%	310↑66.8%
Total Debt	12	6↓47.0%	5↓27.1%	16↑246.7%	12↓23.5%
Net Debt	-180	-64↑64.5%	-77↓20.6%	-132↓70.6%	-124↑5.9%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-25	-46↓88.8%	-53↓13.8%	-51↑2.7%	-71↓37.3%
Capital Expenditure	-2	-18↓727.8%	-2↑87.9%	-0↑85.6%	-1↓151.7%
Free Cash Flow	-27	-65↓141.7%	-55↑15.0%	-52↑6.0%	-71↓38.0%
Stock-Based Comp	0	1	1↑39.7%	1↑13.3%	8↑486.7%
Net Change in Cash	49	-14↓127.7%	11↑183.7%	67↑481.1%	-12↓117.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance